CIPA and KEFEA discuss initiatives to improve Cyprus' pharma investment climate

The potential to attract investments in the pharmaceutical industry and develop joint initiatives to improve the investment climate were discussed during a meeting between the Cyprus Investment Promotion Agency (CIPA) and the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA), which represents the pharmaceutical companies operating in Cyprus.

During the meeting, KEFEA board members as well as CIPA chairman Christodoulos Angastiniotis and director general Charis Papacharalambous analysed the international investment environment in which the two organizations are active, the local field, as well as the latest developments in the Cyprus economy. They also discussed the strategy followed to attract investment in the pharmaceutical sector and stressed the need to implement a sustainable National Health System (NHS) that goes by other European countries’ standards as well as to adopt strategic reforms in the public sector.

Potential for further pharma growth